Advanced search
Start date

Assessment of sorafenib efficacy in experimental liver carcinogenesis secondary to non-alcoholic fatty liver disease (NAFLD) by 18FDG Positron Emission computed tomography (PET-CT)

Grant number: 16/02232-4
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): October 01, 2016
Effective date (End): March 08, 2017
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Jose Tadeu Stefano
Grantee:Bruna Roberta Muntanelli
Home Institution: Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil


Non-alcoholic fatty liver disease (NAFLD) is a worldwide epidemic and may evolve in the long term, to steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma (HCC). There is an immediate need not only to better understand its pathogenesis, but also to develop an effective therapy to prevent progression to more severe forms, as well as, to evaluate methods that methods that enable to differentiate benign lesions from malignant, to determine tumor development phase and monitor the success of the treatments used.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: